-+ 0.00%
-+ 0.00%
-+ 0.00%

Medacta Lowers FY26 Revenue Guidance

MT Newswires·11/05/2026 23:19:02
Listen to the news
11:19 PM EST, 11/05/2026 (MT Newswires) -- Medacta Group (MOVE.SW) adjusted its full-year 2026 revenue guidance while confirming its midterm outlook, according to a Thursday release. The Swiss orthopedic products company now expects revenue growth of 9% in constant currency, against the previous forecast of 10% to 14%. Meanwhile, Medacta reiterated its 2024-2027 midterm guidance of a revenue compound annual growth rate of 12% to 15% in constant currency.